GrantRover ↗

← Tüm fırsatlar

Food and Drug Administration · ABD

Minor Use Minor Species Development of Drugs (R01)

Açık

Food and Drug Administration tarafından hibeler bekleniyor; proje başına $250.000’ye kadar; toplam bütçe $250.000. Başvurular 29 Ocak 2027 tarihinde kapanıyor. Uygun başvuru sahibi türleri (kaynakta): Small businesses, Independent school districts, Special district governments ve 12 diğer.

Son başvuru
29 Ocak 2027 (75 gün kaldı)
Hibe tutarı
Proje başına $250.000’ye kadar
Destek oranı
Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Toplam bütçe
$250.000
Eş finansman
Gerekli değil
Olası başvuru sahipleri
KOBİ’ler / girişimler, Şirketler, Kamu kurumları, Üniversiteler ve araştırma, Kâr amacı gütmeyenler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı
Food and Drug Administration
Referans
PAR-24-216
Destek listesi (ABD)
93.103 Food and Drug Administration Research
Son kontrol
13 Kasım 2026

Resmi çağrıyı aç ↗ Son tarihi takvime ekle

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS).

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

Tam metni oku

FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Kimler başvurabilir

• Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Agriculture Consumer Protection Food and Nutrition

Zamanlama

Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027

Nasıl başvurulur

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

İletişim

Terrin Brown · terrin.brown@fda.hhs.gov · 2404027610

Resmi kaynaklar

Resmi çağrı sayfası · Fon sağlayıcının program sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 13 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.

İlgili fonlar

Food and Drug Administration ABD

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies… (R01 Clinical Trials Optional)

RFA-FD-25-017

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare d…

Food and Drug Administration ABD

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet… (R01 Clinical Trials Required)

RFA-FD-25-020

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change…

U.S. National Science Foundation ABD

Applied Mathematics

PD-16-1266

The Applied Mathematics program supports mathematics research motivated by and contributing to the solution of problems arising in science and engineering. Successful pro…

U.S. National Science Foundation ABD

Astronomy and Astrophysics Research Grants

22-624

The Astronomy and Astrophysics Research Grants (AAG) Program is an inclusive and flexible funding opportunity to support research in the astronomical sciences. The Progra…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…